Effects of iron overload on the activity of Na, K-ATPase and lipid profile of the human erythrocyte membrane

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Sousa, Leilismara ^a   Garcia, Israel J P ^a   Costa, Tamara G F ^a   Silva, Lilian N D ^a   Renó, Cristiane O ^a   Oliveira, Eneida S ^a   Tilelli, Cristiane Q ^a   Santos, Luciana L ^a   Cortes, Vanessa F ^a   Santos, Herica L ^a   Barbosa, Leandro A ^a  

^a FEDERAL UNIVERSITY OF SÃO JOÃO DEL REI   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CHOLESTEROL; FERROUS CHLORIDE; HFE PROTEIN; HYDROGEN PEROXIDE; PHOSPHOLIPID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; LIPID;

ADULT; ARTICLE; BIOCHEMICAL COMPOSITION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; FEMALE; GENE FREQUENCY; HFE GENE; HUMAN; HUMAN CELL; IRON OVERLOAD; LIPID ANALYSIS; LIPID PEROXIDATION; MALE; MUTATIONAL ANALYSIS; OXIDATIVE STRESS; SEX DIFFERENCE; BLOOD; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; MIDDLE AGED;

ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FEMALE; HUMANS; HYDROGEN PEROXIDE; IRON OVERLOAD; LIPID PEROXIDATION; LIPIDS; MALE; MIDDLE AGED; SEX FACTORS; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84941357200     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132852     Document Type: Article

References (74)

1. Santos PCJL, Cançado RD, Terada CT, Guerra-Shinohara EM. Alterações moleculares associadas à hemocromatose hereditária. Revista Brasileira de Hematologia e Hemoterapia. 2009; 31:192-202.
2. Beutler E. Disorders of iron metabolism. In: Lichtman MA, Beutler E, Seligsohn U, Kaushansky K, Kipps TJ, Prchal JT, editors. Williams Hematology. 7 ed. New York: MacGraw-Hill; 2006.
3. Motta VT. Bioquímica Clínica: Princípios e Interpretações. 5 ed. Rio de Janeiro: Medbook; 2009.
4. Moura E, Noordermeer MA, Verhoeven N, Verheul AF, Marx JJ. Iron release from human monocytes after erythrophagocytosis in vitro: An investigation in normal subjects and hereditary hemochromatosis patients. Blood. 1998; 92(7):2511-9. PMID: 9746792.
5. Cançado RD, Chiattone CS. Visão atual da hemocromatose hereditária. Revista Brasileira de Hematologia e Hemoterapia. 2010; 32:469-75.
6. Kumar V, Abbas AK, Fausto N. Patologia: Bases Patológicas das Doenças. 7 ed. Rio de Janeiro: Elsevier; 2005.
7. Brissot P, de Bels F. Current approaches to the management of hemochromatosis. Hematology Am Soc Hematol Educ Program. 2006:36-41. doi:10.1182/asheducation-2006.1.36 PMID: 17124037.
8. de Lima Santos H, Lopes ML, Maggio B, Ciancaglini P. Na, K-ATPase reconstituted in liposomes: effects of lipid composition on hydrolytic activity and enzyme orientation. Colloids Surf B Biointerfaces. 2005; 41(4):239-48. doi:10.1016/j.colsurfb.2004.12.013 PMID: 15748819.
9. Santos HeL Rigos CF, Ciancaglini P. Kinetics behaviors of Na, K-ATPase: comparison of solubilized and DPPC:DPPE-liposome reconstituted enzyme. Comp Biochem Physiol C Toxicol Pharmacol. 2006; 142(3-4):309-16. doi:10.1016/j.cbpc.2005.11.003 PMID: 16413831.
10. Gallagher PG. Disorders of red cell volume regulation. Curr Opin Hematol. 2013; 20(3):201-7. doi:10.1097/Moh.0b013e32835f6870WOS:000317468100003. PMID: 23519154.
11. Delaunay J. The molecular basis of hereditary red cell membrane disorders. Blood reviews. 2007; 21 (1):1-20. doi:10.1016/j.blre.2006.03.005 PMID: 16730867.
12. Sarkadi B, Parker JC. Activation of ion transport pathways by changes in cell volume. Biochimica et biophysica acta. 1991; 1071(4):407-27. PMID: 1721542.
13. Brugnara C, Bunn HF, Tosteson DC. Ion content and transport and the regulation of volume in sickle cells. Annals of the New York Academy of Sciences. 1989; 565:96-103. PMID: 2672974.
14. Bogdanova A, Berenbrink M, Nikinmaa M. Oxygen-dependent ion transport in erythrocytes. Acta physiologica. 2009; 195(3):305-19. doi:10.1111/j.1748-1716.2008.01934.x PMID: 18983458.
15. Pretorius E, Kell DB. Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases. Integrative biology: quantitative biosciences from nano to macro. 2014; 6(5):486-510. doi:10.1039/c4ib00025k PMID: 24714688.
16. Dhar-Chowdhury P, Malester B, Rajacic P, Coetzee WA. The regulation of ion channels and transporters by glycolytically derived ATP. Cellular and molecular life sciences: CMLS. 2007; 64(23):3069-83. doi:10.1007/s00018-007-7332-3 PMID: 17882378.
17. Whittam R, Ager ME. The connexion between active cation transport and metabolism in erythrocytes. Biochem J. 1965; 97(1):214-27. PMID: 16749106; PubMed Central PMCID: PMC1264564.
18. Palmgren MG, Nissen P. P-type ATPases. Annu Rev Biophys. 2011; 40:243-66. doi:10.1146/annurev.biophys.093008.131331 PMID: 21351879.
19. Apell HJ. How do P-type ATPases transport ions? Bioelectrochemistry. 2004; 63(1-2):149-56. doi:10.1016/j.bioelechem.2003.09.021 PMID: 15110265.
20. Kaplan JH. Biochemistry of Na, K-ATPase. Annu Rev Biochem. 2002; 71:511-35. doi:10.1146/annurev.biochem.71.102201.141218 PMID: 12045105.
21. Garty H, Karlish SJ. Role of FXYD proteins in ion transport. Annu Rev Physiol. 2006; 68:431-59. doi:10.1146/annurev.physiol.68.040104.131852 PMID: 16460279.
22. Ogawa H, Toyoshima C. Homology modeling of the cation binding sites of Na+K+-ATPase. Proc Natl Acad Sci U S A. 2002; 99(25):15977-82. doi:10.1073/pnas.202622299 PMID: 12461183; PubMed Central PMCID: PMCPMC138550.
23. Geering K. The functional role of beta subunits in oligomeric P-type ATPases. J Bioenerg Biomembr. 2001; 33(5):425-38. PMID: 11762918.
24. Forbush B, Kaplan JH, Hoffman JF. Characterization of a new photoaffinity derivative of ouabain: labeling of the large polypeptide and of a proteolipid component of the Na, K-ATPase. Biochemistry. 1978; 17(17):3667-76. PMID: 210802.
25. Suhail M. Na, K-ATPase: Ubiquitous Multifunctional Transmembrane Protein and its Relevance to Various Pathophysiological Conditions. J Clin Med Res. 2010; 2(1):1-17. doi:10.4021/jocmr2010.02.263w PMID: 22457695; PubMed Central PMCID: PMCPMC3299169.
26. Hoffman JF, Wickrema A, Potapova O, Milanick M, Yingst DR. Na pump isoforms in human erythroid progenitor cells and mature erythrocytes. Proc Natl Acad Sci U S A. 2002; 99(22):14572-7. doi:10.1073/pnas.222539999 PMID: 12388775; PubMed Central PMCID: PMCPMC137924.
27. Else PL, Wu BJ. What role for membranes in determining the higher sodium pump molecular activity of mammals compared to ectotherms? J Comp Physiol B. 1999; 169(4-5):296-302. PMID: 10466220.
28. Cornelius F. Modulation of Na, K-ATPase and Na-ATPase activity by phospholipids and cholesterol. I. Steady-state kinetics. Biochemistry. 2001; 40(30):8842-51. PMID: 11467945.
29. Yin W, Jiang G, Takeyasu K, Zhou X. Stimulation of Na, K-ATPase by low potassium is dependent on transferrin. J Membr Biol. 2003; 193(3):177-84. doi:10.1007/s00232-003-2016-x PMID: 12962278.
30. Rega AF, Garrahan PJ, Barrabin H, Horenstein A, Rossi JP. Cation flux across biomembranes. New York: Academic; 1979. p. 67-76.
31. Adams PE. Determining Iron Content in Foods by Spectrophotometry. Journal of Chemical Education. 1995; 72(7):649. doi:10.1021/ed072p649.
32. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978; 52:302-10. PMID: 672633.
33. Fiske CH, Subbarow Y. THE COLORIMETRIC DETERMINATION OF PHOSPHORUS. Journal of Biological Chemistry. 1925; 66(2):375-400.
34. Rose HG, Oklander M. Improved procedure for the extraction of lipids from the human erythrocytes. J Lipid Res. 1965; 6:428-31. PMID: 14336214.
35. Vokurková M, Nováková O, Dobesová Z, Kunes J, Zicha J. Relationships between membrane lipids and ion transport in red blood cells of Dahl rats. Life Sci. 2005; 77(13):1452-64. doi:10.1016/j.lfs.2005.03.014 PMID: 15936778.
36. Chen PS, Toribara TY, Warner H. Microdetermination of Phosphorus. Analytical Chemistry. 1956; 28 (11):1756-8. doi:10.1021/ac60119a033.
37. Higgins ET. Self-discrepancy: A theory relating self and affect. Psychol Rev. 1987; 94(3):319-40. PMID: 3615707.
38. Zhou X, Yin W, Doi SQ, Robinson SW, Takeyasu K, Fan X. Stimulation of Na, K-ATPase by low potassium requires reactive oxygen species. Am J Physiol Cell Physiol. 2003; 285(2):C319-26. doi:10.1152/ajpcell.00536.2002 PMID: 12686517.
39. Turi JL, Piantadosi CA, Stonehuerner JD, Ghio AJ. Iron accumulation in bronchial epithelial cells is dependent on concurrent sodium transport. Biometals. 2008; 21(5):571-80. doi:10.1007/s10534-008-9143-x PMID: 18483768; PubMed Central PMCID: PMCPMC2705954.
40. Mendanha SA, Anjos JL, Silva AH, Alonso A. Electron paramagnetic resonance study of lipid and protein membrane components of erythrocytes oxidized with hydrogen peroxide. Braz J Med Biol Res. 2012; 45(6):473-81. Epub 2012/04/05. S0100-879X2012007500050 [pii]. PMID: 22473321; PubMed Central PMCID: PMC3854297.
41. Hollan S. Membrane fluidity of blood cells. Haematologia (Budap). 1996; 27(3):109-27. Epub 1996/01/01. PMID: 14653448.
42. Almeida AM, Bertoncini CR, Borecký J, Souza-Pinto NC, Vercesi AE. Mitochondrial DNA damage associated with lipid peroxidation of the mitochondrial membrane induced by Fe2+-citrate. An Acad Bras Cienc. 2006; 78(3):505-14. PMID: 16936939.
43. Young IS, Trouton TG, Torney JJ, McMaster D, Callender ME, Trimble ER. Antioxidant status and lipid peroxidation in hereditary haemochromatosis. Free Radic Biol Med. 1994; 16(3):393-7. PMID: 8063202.
44. Britton RS, O'Neill R, Bacon BR. Hepatic mitochondrial malondialdehyde metabolism in rats with chronic iron overload. Hepatology. 1990; 11(1):93-7. PMID: 2295476.
45. Pretorius E. The adaptability of red blood cells. Cardiovasc Diabetol. 2013; 12. Artn 63 doi:10.1186/1475-2840-12-63 ISI:000318049500001. PMID: 23578325.
46. Pretorius E, Bester J, Vermeulen N, Lipinski B, Gericke GS, Kell DB. Profound Morphological Changes in the Erythrocytes and Fibrin Networks of Patients with Hemochromatosis or with Hyperferritinemia, and Their Normalization by Iron Chelators and Other Agents. Plos One. 2014; 9(1). ARTN e85271 doi:10.1371/journal.pone.0085271 ISI:000329866300062. PMID: 24416376.
47. Pretorius E, Vermeulen N, Bester J, du Plooy JL, Gericke GS. The effect of iron overload on red blood cell morphology. Lancet. 2014; 383(9918):722. doi:10.1016/S0140-6736(13)61208-8 ISI:000331653300033. PMID: 24486189.
48. Cluitmans JC, Hardeman MR, Dinkla S, Brock R, Bosman GJ. Red blood cell deformability during storage: Towards functional proteomics and metabolomics in the Blood Bank. Blood Transfus. 2012; 10 Suppl 2:s12-8. doi:10.2450/2012.004s PMID: 22890263; PubMed Central PMCID: PMCPMC3418616.
49. Esmann M, Marsh D. Lipid-protein interactions with the Na, K-ATPase. Chem Phys Lipids. 2006; 141 (1-2):94-104. doi:10.1016/j.chemphyslip.2006.02.018 PMID: 16580658.
50. Rodrigo R, Bächler JP, Araya J, Prat H, Passalacqua W. Relationship between (Na + K)-ATPase activity, lipid peroxidation and fatty acid profile in erythrocytes of hypertensive and normotensive subjects. Mol Cell Biochem. 2007; 303(1-2):73-81. doi:10.1007/s11010-007-9457-y PMID: 17410406.
51. Cornelius F, Habeck M, Kanai R, Toyoshima C, Karlish SJ. General and specific lipid-protein interactions in Na, K-ATPase. Biochimica et biophysica acta. 2015. Epub 2015/03/21. S0005-2736(15)00091- 7 [pii]doi:10.1016/j.bbamem.2015.03.012 PMID: 25791351.
52. Cornelius F. Cholesterol modulation of molecular activity of reconstituted shark Na+, K(+)-ATPase. Biochimica et biophysica acta. 1995; 1235(2):205-12. Epub 1995/05/04. 0005-2736(95)80006-2 [pii]. PMID: 7756327.
53. Claret M, Garay R, Giraud F. The effect of membrane cholesterol on the sodium pump in red blood cells. J Physiol. 1978; 274:247-63. Epub 1978/01/01. PMID: 624995; PubMed Central PMCID: PMC1282488.
54. Ogawa H, Shinoda T, Cornelius F, Toyoshima C. Crystal structure of the sodium-potassium pump (Na +, K+-ATPase) with bound potassium and ouabain. Proc Natl Acad Sci U S A. 2009; 106(33):13742-7. Epub 2009/08/12. 0907054106 [pii] doi:10.1073/pnas.0907054106 PMID: 19666591; PubMed Central PMCID: PMC2728964.
55. Morth JP, Pedersen BP, Toustrup-Jensen MS, Sorensen TL, Petersen J, Andersen JP, et al. Crystal structure of the sodium-potassium pump. Nature. 2007; 450(7172):1043-9. Epub 2007/12/14. nature06419 [pii] doi:10.1038/nature06419 PMID: 18075585.
56. Haro KJ, Sheth A, Scheinberg DA. Dysregulation of IRP1-mediated iron metabolism causes gamma ray-specific radioresistance in leukemia cells. Plos One. 2012; 7(11):e48841. Epub 2012/11/17. doi:10.1371/journal.pone.0048841PONE-D-12-11363 [pii]. PMID: 23155415; PubMed Central PMCID: PMC3498264.
57. Goldshleger R, Karlish SJ. Fe-catalyzed cleavage of the alpha subunit of Na/K-ATPase: evidence for conformation-sensitive interactions between cytoplasmic domains. Proc Natl Acad Sci U S A. 1997; 94 (18):9596-601. PMID: 9275168; PubMed Central PMCID: PMC23229.
58. Goldshleger R, Karlish SJ. The energy transduction mechanism of Na, K-ATPase studied with iron-catalyzed oxidative cleavage. J Biol Chem. 1999; 274(23):16213-21. PMID: 10347176.
59. Santos PC, Cançado RD, Pereira AC, Schettert IT, Soares RA, Pagliusi RA, et al. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients. Blood Cells Mol Dis. 2011; 46(4):302-7. doi:10.1016/j.bcmd.2011.02.008 PMID: 21411349.
60. Cançado RD, Guglielmi AC, Vergueiro CS, Rolim EG, Figueiredo MS, Chiattone CS. Analysis of HFE gene mutations and HLA-A alleles in Brazilian patients with iron overload. Sao Paulo Med J. 2006; 124 (2):55-60. PMID: 16878186.
61. Santos PC, Pereira AC, Cançado RD, Schettert IT, Sobreira TJ, Oliveira PS, et al. HFE gene mutations in patients with primary iron overload: is there a significant improvement in molecular diagnosis yield with HFE sequencing? Blood Cells Mol Dis. 2010; 45(4):302-7. doi:10.1016/j.bcmd.2010.08.008 PMID: 20843714.
62. Leão GDR, Oliveira TMM, Fernandes TMM, Freire JM, Vasconcelos RC, Farias MVMC, et al. Analysis of C282Y and H63D mutations of the HFE gene in patients with persistent hyperferritinemia. Journal of Medicine and Medical Sciences. 2010; 1(10):453-59.
63. Bittencourt PL, Marin ML, Couto CA, Cançado EL, Carrilho FJ, Goldberg AC. Analysis of HFE and non- HFE gene mutations in Brazilian patients with hemochromatosis. Clinics (Sao Paulo). 2009; 64(9):837- 41. doi:10.1590/s1807-59322009000900003 PMID: 19759876; PubMed Central PMCID: PMCPMC2745139.
64. Calado RT, Franco RF, Pazin-Filho A, Simões MV, Marin-Neto JA, Zago MA. HFE gene mutations in coronary atherothrombotic disease. Braz J Med Biol Res. 2000; 33(3):301-6. PMID: 10719381.
65. Bueno S, Duch CR, Figueiredo MS. Mutations in the HFE gene (C282Y, H63D, S65C) in a Brazilian population. Revista Brasileira de Hematologia e Hemoterapia. 2006; 28:293-5.
66. Oliveira TM, Souza FP, Jardim AC, Cordeiro JA, Pinho JR, Sitnik R, et al. HFE gene mutations in Brazilian thalassemic patients. Braz J Med Biol Res. 2006; 39(12):1575-80. 17160266. PMID: 17160266.
67. Kelley M, Joshi N, Xie YG, Borgaonkar M. Iron overload is rare in patients homozygous for the H63D mutation. Can J Gastroenterol. 2014; 28(4):198-202. ISI:000334402400007.
68. Adams PC. Epidemiology and diagnostic testing for hemochromatosis and iron overload. Int J Lab Hematol. 2015; 37 Suppl 1:25-30. Epub 2015/05/16. doi:10.1111/ijlh.12347 PMID: 25976957.
69. Cançado RD, Guglielmi ACO, Vergueiro CSV, Rolim EG, Figueiredo MS, Chiattone CS. Estudo das mutações C282Y, H63D e S65C do gene HFE em doentes brasileiros com sobrecarga de ferro. Revista Brasileira de Hematologia e Hemoterapia. 2007; 29:351-60.
70. Oliveira VC, Caxito FA, Gomes KB, Castro AM, Pardini VC, Ferreira AC. Frequency of the S65C mutation in the hemochromatosis gene in Brazil. Genet Mol Res. 2009; 8(3):794-8. PMID: 19681031.
71. Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology. 2010; 139(2):393-408, .e1-2. doi:10.1053/j.gastro.2010.06.013 PMID: 20542038.
72. Pietrangelo A. Hereditary hemochromatosis-a new look at an old disease. N Engl J Med. 2004; 350 (23):2383-97. doi:10.1056/NEJMra031573 PMID: 15175440.
73. Yen AW, Fancher TL, Bowlus CL. Revisiting hereditary hemochromatosis: current concepts and progress. Am J Med. 2006; 119(5):391-9. doi:10.1016/j.amjmed.2005.10.041 PMID: 16651049.
74. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology. 1997; 25(1):162-6. doi:10.1002/hep.510250130 PMID: 8985284.